February 19, 2015 — Accuray Inc. announced that the first TomoTherapy System in Latin America dedicated solely to the treatment of breast cancer is now operational at FUCAM (Fundacion de Cancer de Mama) in Mexico City. More than 120 women have been treated with the radiation-therapy technology since the center began using it more than two months ago.
The TomoTherapy System is specifically designed for image-guided intensity-modulated radiation therapy (IG-IMRT). Leveraging a computed tomography (CT) scanner-based platform, TomoHelical Mode enables continuous delivery from 360 degrees around the patient with highly conformal and homogeneous dose to the tumor. A clinician can also choose to deliver treatment from specific fixed angles via TomoDirect Mode. With the TomoTherapy System, highly-sculpted dose distributions are achievable for the full range of breast cancer cases, from routine to complex.
“We (FUCAM) are a reference center for breast cancer patients, receiving about 1,000 new cases per year, so it was critical that we select a versatile and efficient radiation therapy system capable of delivering both hypofractionated and non-hypofractionated treatments to address a variety of patient needs,” said Judith Huerta Bahena, M.D., head of radiotherapy, Institute of Diseases of the Breast, FUCAM. “We considered TomoTherapy to be the ideal system for us based on recent studies demonstrating the system provides superior dose homogeneity with a lower dose to normal tissue, when compared to conventional treatments.”
For more information: www.accuray.com
July 07, 2026 
